PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Parkinson Disease D010300 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Peritonitis D010538 38 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Pleurisy D010998 20 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Respiratory Sounds D012135 3 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Rhinitis D012220 10 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Sarcoidosis D012507 13 associated lipids
Sarcoma 180 D012510 21 associated lipids
Osteosarcoma D012516 50 associated lipids
Seizures D012640 87 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Sneezing D012912 6 associated lipids
Stomach Ulcer D013276 75 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombosis D013927 49 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Translocation, Genetic D014178 20 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Uremia D014511 33 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Urticaria D014581 13 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Wounds, Stab D014951 3 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Loss D015431 56 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
HTLV-I Infections D015490 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Choroid Diseases D015862 2 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Coronavirus Infections D018352 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Endotoxemia D019446 27 associated lipids
Thrombophilia D019851 6 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Stroke D020521 32 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Fetal Weight D020567 12 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Coronary Restenosis D023903 10 associated lipids
Tauopathies D024801 6 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Decapitation D049248 2 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Acute Lung Injury D055371 33 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Airway Remodeling D056151 3 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
González E et al. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. 2002 Nitric Oxide pmid:11890746
Monneret G et al. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. 2002 J. Immunol. pmid:11907120
Hayaishi O and Urade Y Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. 2002 Neuroscientist pmid:11843094
Harris SG and Phipps RP Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. 2002 Immunology pmid:11849312
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. 2002 Pancreas pmid:11854617
Diab A et al. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. 2002 J. Immunol. pmid:11859145
Adams IR and McLaren A Sexually dimorphic development of mouse primordial germ cells: switching from oogenesis to spermatogenesis. 2002 Development pmid:11874911
Dieter P et al. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. 2002 Cell. Signal. pmid:11812647
Michimata T et al. Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D(2)-mediated manner. 2002 Mol. Hum. Reprod. pmid:11818521
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. 2002 J. Biol. Chem. pmid:11606585
Chen SY et al. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress. 2002 Anticancer Drugs pmid:12187333
Yamamoto S et al. Agents that elevate cyclic AMP induce receptor phosphorylation primarily at serine 331 in HEK 293 cells overexpressing human thromboxane receptor alpha. 2002 Biochem. Pharmacol. pmid:12147288
Sakurai S et al. Retinal capillary pericyte proliferation and c-Fos mRNA induction by prostaglandin D2 through the cAMP response element. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12147615
Saito S et al. Prostaglandin D2 and reproduction. 2002 Am. J. Reprod. Immunol. pmid:12148545
Gong P et al. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. 2002 Antioxid. Redox Signal. pmid:12006176
Hong JT et al. Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. 2002 J. Toxicol. Environ. Health Part A pmid:11936221
Mujumdar VS et al. Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. 2002 Am. J. Physiol., Cell Physiol. pmid:11940516
Padilla J et al. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. 2002 Clin. Immunol. pmid:11987982
Natarajan C and Bright JJ Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. 2002 Genes Immun. pmid:11960303
Cuzzocrea S et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. 2002 Mol. Pharmacol. pmid:11961117
Kojima K et al. Effect of PPARgamma ligands on the viability of gastric epithelial cells. 2002 Aliment. Pharmacol. Ther. pmid:11966526
Lee B et al. Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. 2002 J. Neurosci. pmid:12097519
Iwasaki M et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. 2002 J. Invest. Dermatol. pmid:12230502
Jozkowicz A et al. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. 2002 Antioxid. Redox Signal. pmid:12230869
Haslmayer P et al. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. 2002 Int. J. Oncol. pmid:12239635
Clay CE et al. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. 2002 J. Lipid Res. pmid:12401880
Imaizumi T et al. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. 2002 Immunol. Cell Biol. pmid:12406386
Kim SY et al. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. 2002 Phytother Res pmid:12410540
Jawerbaum A et al. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. 2002 Reproduction pmid:12417000
Kubata BK et al. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. 2002 J. Exp. Med. pmid:12417633
Menè P Prostaglandin D2 : a Cinderella of vascular cell biology? 2002 J. Hypertens. pmid:12131515
Negoro H et al. Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. 2002 J. Hypertens. pmid:12131531
Stubbs VE et al. Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. 2002 J. Biol. Chem. pmid:11980903
Larsen P et al. Calcium-stimulated short-circuit currents in the canine proximal colonic epithelium: effects of DK-PGD2, a metabolite of prostaglandin D2. 2002 Can. J. Physiol. Pharmacol. pmid:12489928
Satoh T [Neurotrophin-like low molecular weight compounds]. 2002 Nippon Yakurigaku Zasshi pmid:12491808
Gueck T et al. Influence of vitamin E on mast cell mediator release. 2002 Vet. Dermatol. pmid:12464062
Sawyer N et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. 2002 Br. J. Pharmacol. pmid:12466225
Li L et al. 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. 2001 J. Biol. Chem. pmid:11477100
Ahluwalia P et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. 2001 J. Allergy Clin. Immunol. pmid:11544467
Nicolaidis S et al. [Variations of hypothalamic and cortical prostaglandins and monoamines reveal transitions in arousal states: microdialysis study in the rat]. 2001 Rev. Neurol. (Paris) pmid:11924034
Keelan J et al. 15-deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11785780
Pignatelli M et al. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. 2001 J. Cell. Sci. pmid:11739643
Gervais FG et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. 2001 J. Allergy Clin. Immunol. pmid:11742277
Reilly TP et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. 2001 Chem. Res. Toxicol. pmid:11743745
Tomlinson JW et al. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. 2001 Endocrinology pmid:11316764
Thévenon C et al. Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. 2001 Clin. Chem. pmid:11274037
Rohn TT et al. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. 2001 Neuroreport pmid:11277593
Satoh T et al. Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. 2001 J. Neurochem. pmid:11279261
Drew PD and Chavis JA The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. 2001 J. Neuroimmunol. pmid:11282151
Guyton K et al. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. 2001 J. Leukoc. Biol. pmid:11310850
Govoni S et al. The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. 2001 Neurosci. Lett. pmid:11311500
Tsubouchi Y et al. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. 2001 Biochem. Biophys. Res. Commun. pmid:11350047
Wang C et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. 2001 Mol. Cell. Biol. pmid:11287611
Jiang JG et al. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. 2001 J. Biol. Chem. pmid:11292834
Serghides L and Kain KC Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. 2001 J. Immunol. pmid:11359831
Urquhart P et al. Profile of eicosanoids produced by human saphenous vein endothelial cells and the effect of dietary fatty acids. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11487303
Angeli V et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. 2001 J. Exp. Med. pmid:11369785
Krawiec ME et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. 2001 Am. J. Respir. Crit. Care Med. pmid:11371398
Saarinen JV et al. Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. 2001 Eur. J. Clin. Pharmacol. pmid:11372583
Buechler C et al. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. 2001 Biochim. Biophys. Acta pmid:11420178
VanderEnde DS and Morrow JD Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. 2001 J. Am. Acad. Dermatol. pmid:11423836
Park JM Role of prostaglandins in bladder smooth muscle cell gene expression. 2001 Urology pmid:11378068
Chang TS et al. NQ-Y15 inhibits the calcium mobilization by elevation of cyclic AMP in rat platelets. 2001 Biol. Pharm. Bull. pmid:11379764
Fajas L et al. PPAR gamma: an essential role in metabolic control. 2001 Nutr Metab Cardiovasc Dis pmid:11383325
Boutaud O et al. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid. 2001 Biochemistry pmid:11389610
Chen NG and Han X Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. 2001 Biochem. Biophys. Res. Commun. pmid:11401521
Lau HY and Chan CL Modulation of intracellular cyclic AMP in immunologically activated rat peritoneal mast cells by prostaglandin D2. 2001 Inflamm. Res. pmid:11411605
Serhan CN and Devchand PR Novel antiinflammatory targets for asthma. A role for PPARgamma? 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415929
Guan Y et al. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. 2001 Am. J. Physiol. Renal Physiol. pmid:11704554
Bochenek G et al. [Prostaglandin D2: biosynthesis, biological properties and participation in bronchial asthma]. 2001 Pol. Arch. Med. Wewn. pmid:11928572
Azuma Y et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages. 2001 Biochem. Biophys. Res. Commun. pmid:11327705
Wilmer WA et al. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. 2001 Biochem. Biophys. Res. Commun. pmid:11178960
Kang SS et al. Cyclooxygenase-2 inhibitory cerebrosides from phytolaccae radix. 2001 Chem. Pharm. Bull. pmid:11253924
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Fahmi H et al. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. 2001 Arthritis Rheum. pmid:11263774
Hsieh FH et al. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. 2001 J. Exp. Med. pmid:11136826
Tunaz H et al. Prostaglandin biosynthesis by fat body from true armyworms, Pseudaletia unipuncta. 2001 Insect Biochem. Mol. Biol. pmid:11222953
Person EC et al. Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo. 2001 Endocrinology pmid:11159824
Reilly CM et al. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. 2001 Clin. Immunol. pmid:11237557
Kitamura Y et al. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. 2001 Eur. J. Pharmacol. pmid:11164379
Kadekaro M et al. Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats. 2001 Brain Res. pmid:11166690
Szczeklik A et al. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. 2001 Clin. Exp. Allergy pmid:11251623
Nielsen PN et al. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. 2001 Clin. Exp. Allergy pmid:11591187
Tanimoto A et al. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. 2001 FEBS Lett. pmid:11728449
Yamamoto K et al. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. 2001 Circulation pmid:11581147
Mizoguchi A et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11562489
Inoue K et al. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. 2001 Biochem. Biophys. Res. Commun. pmid:11563856
Clay CE et al. Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells. 2001 J. Biol. Chem. pmid:11668172
Monneret G et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. 2001 Blood pmid:11535533
Akrishnan VR and Menon VP Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats. 2001 Cell Biol. Toxicol. pmid:11504446
Chiba Y et al. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells. 2001 Biochem. Biophys. Res. Commun. pmid:11511093
Kozawa O et al. Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. 2001 Cell. Signal. pmid:11483406
Nakashiro KI et al. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. 2001 Am. J. Pathol. pmid:11485917
Takashima T et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. 2001 Int. J. Oncol. pmid:11494023
Rovin BH et al. Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. 2001 J. Am. Soc. Nephrol. pmid:11461938
Cernuda-Morollón E et al. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. 2001 J. Biol. Chem. pmid:11466314
Boyault S et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. 2001 FEBS Lett. pmid:11457450
Nishimura H et al. Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. 2001 Prostaglandins Other Lipid Mediat. pmid:11519790
Clay CE et al. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. 2001 J. Investig. Med. pmid:11523697
Hunter JG et al. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways. 2001 J. Biol. Chem. pmid:11477074